Showing results (51-60 of 625) with videos related to
Sort By:
Pageof 63
Cancers|April 13, 2023
Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical TumorsAlexandra Lainé, Andrea M Gonzalez-Lopez, Uzma Hasan, et al.Current Opinion in Oncology|June 11, 2009
Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?Jean-Yves Blay, Antoine Adenis, Isabelle Ray-Coquard, et al.Frontiers in Oncology|January 26, 2024
HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trialMichel Fabbro, Pierre-Jean Lamy, Célia Touraine, et al.Applied Immunohistochemistry & Molecular Morphology : AIMM|March 10, 2015
Myxoid liposarcoma with heterologous components: dedifferentiation or metaplasia? A FISH-documented and CGH-documented case reportNoëlle Weingertner, Agnès Neuville, Frédéric Chibon, et al.The European Journal of General Practice|July 18, 2020
Cancer screening and follow-up in general practice: A French nationwide cross-sectional studyMarion Lamort-Bouché, Marine Chardon, Nadir Kellou, et al.Expert Opinion on Investigational Drugs|February 21, 2023
Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?Ignace Vergote, Isabelle Ray-Coquard, Domenica Lorusso, et al.The Oncologist|November 30, 2005
ET-743: a novel agent with activity in soft tissue sarcomasJérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.Current Oncology Reports|November 9, 2021
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab TherapyAlexandra Lainé, Travis T Sims, Olivia Le Saux, et al.Critical Reviews in Oncology/Hematology|August 7, 2024
Impact of molecular testing on the surgical management of advanced epithelial ovarian cancerPierre-Emmanuel Colombo, Christophe Taoum, Michel Fabbro, et al.Pageof 63